메뉴 건너뛰기




Volumn 376, Issue 20, 2017, Pages 1997-

The authors reply

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; IRON; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR;

EID: 85019898923     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1703377     Document Type: Letter
Times cited : (45)

References (5)
  • 1
    • 84994508611 scopus 로고    scopus 로고
    • Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): A 28 week, multicentre, double-blind, phase 3, randomised controlled trial
    • Frías JP, Guja C, Hardy E, et al. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial. Lancet Diabetes Endocrinol 2016;4:1004-16.
    • (2016) Lancet Diabetes Endocrinol , vol.4 , pp. 1004-1016
    • Frías, J.P.1    Guja, C.2    Hardy, E.3
  • 2
    • 2342652451 scopus 로고    scopus 로고
    • A systematic review of adherence with medications for diabetes
    • Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218-24.
    • (2004) Diabetes Care , vol.27 , pp. 1218-1224
    • Cramer, J.A.1
  • 3
    • 84971268454 scopus 로고    scopus 로고
    • Metabolic surgery in the treatment algorithm for type 2 diabetes: A joint statement by international diabetes organizations
    • Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 2016;39:861-77.
    • (2016) Diabetes Care , vol.39 , pp. 861-877
    • Rubino, F.1    Nathan, D.M.2    Eckel, R.H.3
  • 4
    • 84971249089 scopus 로고    scopus 로고
    • Identifying barriers to appropriate use of metabolic/bariatric surgery for type 2 diabetes treatment: Policy lab results
    • Rubin JK, Hinrichs-Krapels S, Hesketh R, Martin A, Herman WH, Rubino F. Identifying barriers to appropriate use of metabolic/bariatric surgery for type 2 diabetes treatment: policy lab results. Diabetes Care 2016;39:954-63.
    • (2016) Diabetes Care , vol.39 , pp. 954-963
    • Rubin, J.K.1    Hinrichs-Krapels, S.2    Hesketh, R.3    Martin, A.4    Herman, W.H.5    Rubino, F.6
  • 5
    • 84876217657 scopus 로고    scopus 로고
    • Clinical practice guidelines for the perioperative nutritional, metabolic, and non-surgical support of the bariatric surgery patient - 2013 Update: Cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery
    • Silver Spring
    • Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and non-surgical support of the bariatric surgery patient - 2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) 2013;21:Suppl 1:S1-27.
    • (2013) Obesity , vol.21 , pp. S1-S27
    • Mechanick, J.I.1    Youdim, A.2    Jones, D.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.